Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas
Maud Toulmonde1, Nicolas Penel2, Julien Adam3,4, Christine Chevreau5, Jean‐Yves Blay6, Axel Le Cesne7, Emmanuelle Bompas8, Sophie Piperno‐Neumann9, Sophie Cousin1, Thomas Grellety1, Thomas Ryckewaert10, Alban Bessede11, François Ghiringhelli12, Marina Pulido13,14, Antoîne Italiano1
1Department of Medical Oncology, Institut Bergonié, Bordeaux, France
2Department of Medical Oncology, Centre Oscar Lambret, Bordeaux, France
3Department of Pathology, Gustave Roussy, Villejuif, France
4INSERM U981, Villejuif, France
5Department of Medical Oncology, Oncopole Toulouse, Toulouse France
6Department of medical oncology, Centre Leon Berard, Lyon, France
7Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France
8Department of Medical Oncology, Institut de Cancérologie de l'OUEST, Nantes, France
9Department of Medical Oncology, Institut Curie, Paris, France
10Department of Medical Oncology, Centre Oscar Lambret, Lille, France
11Immusmol, Bordeaux, France
12INSERM, Dijon, France
13INSERM CIC 1401, Bordeaux, France
14Unité de Recherche et D'Epidémiologie Cliniques, Institut Bergonié, Bordeaux, France